Simply Wall St.
How Amgen’s New CD19-Targeted gMG Approval At Amgen (AMGN) Has Changed Its Investment Story
📊
AI Sentiment
Positive
7/10
Amgen Inc. News
Latest updates and market news for AMGN
11 news
Dec 11 - Dec 17, 2025
Page 1
Investor's Business Daily
Stock Market Today: Dow Dips Amid Ukraine-Russia Progress; Trump Eyes This Fed Move (Live Coverage)
➖
AI Sentiment
Neutral
5/10
Simply Wall St.
Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Morgan Stanley Adjusts Amgen Price Target to $304 From $329, Maintains Equalweight Rating
📊
AI Sentiment
Positive
7/10
Zacks
Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Amgen Says FDA Approves Uplizna For Autoimmune Disorder Treatment
📊
AI Sentiment
Positive
7/10
PR Newswire
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Amgen Insiders Sell US$15m Of Stock, Possibly Signalling Caution
➖
AI Sentiment
Neutral
4/10
Share this news page